These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17016895)

  • 21. Early clinical response to different therapeutic regimens for human brucellosis.
    Malik GM
    Am J Trop Med Hyg; 1998 Feb; 58(2):190-1. PubMed ID: 9502602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antibiotic treatment of brucellosis].
    Bertrand A
    Presse Med; 1994 Jun; 23(24):1128-31. PubMed ID: 7971834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179].
    Karabay O; Sencan I; Kayas D; Sahin I
    BMC Infect Dis; 2004 Jun; 4():18. PubMed ID: 15214959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of human brucellosis with doxycycline and gentamicin.
    Solera J; Espinosa A; Martínez-Alfaro E; Sánchez L; Geijo P; Navarro E; Escribano J; Fernández JA
    Antimicrob Agents Chemother; 1997 Jan; 41(1):80-4. PubMed ID: 8980759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmune hepatitis triggered by Brucella infection or doxycycline or both.
    Selimoglu MA; Ertekin V
    Int J Clin Pract; 2003 Sep; 57(7):639-41. PubMed ID: 14529072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Root discolouration following short-term application of steroid medicaments containing clindamycin, doxycycline or demeclocycline.
    Chen BK; George R; Walsh LJ
    Aust Endod J; 2012 Dec; 38(3):124-8. PubMed ID: 23211072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ciprofloxacin and rifampicin versus doxycycline and rifampicin in the treatment of brucellosis.
    Agalar C; Usubutun S; Turkyilmaz R
    Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):535-8. PubMed ID: 10517189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two durations of triple-drug therapy in patients with uncomplicated brucellosis: A randomized controlled trial.
    Sofian M; Velayati AA; Aghakhani A; McFarland W; Farazi AA; Banifazl M; Eslamifar A; Ramezani A
    Scand J Infect Dis; 2014 Aug; 46(8):573-7. PubMed ID: 24934986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on treatment options for spinal brucellosis.
    Ulu-Kilic A; Karakas A; Erdem H; Turker T; Inal AS; Ak O; Turan H; Kazak E; Inan A; Duygu F; Demiraslan H; Kader C; Sener A; Dayan S; Deveci O; Tekin R; Saltoglu N; Aydın M; Horasan ES; Gul HC; Ceylan B; Kadanalı A; Karabay O; Karagoz G; Kayabas U; Turhan V; Engin D; Gulsun S; Elaldı N; Alabay S
    Clin Microbiol Infect; 2014 Feb; 20(2):O75-82. PubMed ID: 24118178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis.
    Saltoglu N; Tasova Y; Inal AS; Seki T; Aksu HS
    Saudi Med J; 2002 Aug; 23(8):921-4. PubMed ID: 12235463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: a prospective, randomized study.
    Bayindir Y; Sonmez E; Aladag A; Buyukberber N
    J Chemother; 2003 Oct; 15(5):466-71. PubMed ID: 14598939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Discoloration of teeth by drugs].
    de Wit ME; Stricker BH; Porsius AJ
    Ned Tijdschr Tandheelkd; 1996 Jan; 103(1):3-5. PubMed ID: 11921968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doxycycline-induced drug fever: a case report.
    Yuan HL; Lu NW; Xie H; Zheng YY; Wang QH
    Infect Dis (Lond); 2016; 48(11-12):844-6. PubMed ID: 27339030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of therapeutic failure among patients with acute brucellosis treated by dual therapy with doxycycline-rifampin.
    Alsayed Hasanain AF; El-Masry MA; Zayed AAH; Nafee AMA; Attia RAH; Abdel-Aal SM
    Trop Med Int Health; 2019 Feb; 24(2):185-191. PubMed ID: 30411836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing efficacy and safety of high-dose and standard-dose rifampicin in the treatment of brucellosis: a randomized clinical trial.
    Salehi M; Farbod F; Khalili H; Rahmani H; Jafari S; Abbasi A
    J Antimicrob Chemother; 2023 Apr; 78(4):1084-1091. PubMed ID: 36880215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind study to assess the optimal duration of doxycycline treatment for human brucellosis.
    Solera J; Geijo P; Largo J; Rodriguez-Zapata M; Gijón J; Martinez-Alfaro E; Navarro E; Macia MA;
    Clin Infect Dis; 2004 Dec; 39(12):1776-82. PubMed ID: 15578399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxycycline and Tooth Discoloration in Children: Changing of Recommendations Based on Evidence of Safety.
    Stultz JS; Eiland LS
    Ann Pharmacother; 2019 Nov; 53(11):1162-1166. PubMed ID: 31280586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis.
    Montejo JM; Alberola I; Glez-Zarate P; Alvarez A; Alonso J; Canovas A; Aguirre C
    Clin Infect Dis; 1993 May; 16(5):671-6. PubMed ID: 8507759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of two regimens in the treatment of brucellosis.
    Rodriguez Zapata M; Gamo Herranz A; De La Morena Fernández J
    Chemioterapia; 1987 Jun; 6(2 Suppl):360-2. PubMed ID: 3334575
    [No Abstract]   [Full Text] [Related]  

  • 40. How safe is doxycycline for young children or for pregnant or breastfeeding women?
    Wormser GP; Wormser RP; Strle F; Myers R; Cunha BA
    Diagn Microbiol Infect Dis; 2019 Mar; 93(3):238-242. PubMed ID: 30442509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.